Ramkamal Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 03-01-2025
- Paid Up Capital ₹ 1.50 Cr
as on 03-01-2025
- Company Age 28 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 15.88 Cr
as on 03-01-2025
- Satisfied Charges ₹ 2.12 Cr
as on 03-01-2025
- Revenue -15.75%
(FY 2022)
- Profit 172.26%
(FY 2022)
- Ebitda 691.65%
(FY 2022)
- Net Worth 35.52%
(FY 2022)
- Total Assets -14.20%
(FY 2022)
About Ramkamal Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹15.88 Cr. The company has closed loans amounting to ₹2.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sahabuddin Khan, Sirajuddin Khan, and Sadruddin Khan serve as directors at the Company.
- CIN/LLPIN
U99999MH1996PTC100977
- Company No.
100977
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 1996
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Social Media-
Who are the key members and board of directors at Ramkamal Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahabuddin Khan  | Director | 06-May-2010 | Current |
| Sirajuddin Khan | Additional Director | 29-May-2023 | Current |
| Sadruddin Khan | Director | 06-May-2010 | Current |
Financial Performance of Ramkamal Chemicals.
Ramkamal Chemicals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 15.75% decrease. The company also saw a substantial improvement in profitability, with a 172.26% increase in profit. The company's net worth Soared by an impressive increase of 35.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ramkamal Chemicals?
In 2022, Ramkamal Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Annex Pharmaceutical & Chemicals Private LimitedActive 18 years 8 monthsSahabuddin Khan, Sirajuddin Khan and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Dec 2021 | ₹8.00 M | Open |
Others Creation Date: 05 Feb 2021 | ₹1.14 Cr | Open |
Others Creation Date: 14 Jul 2020 | ₹2.00 Cr | Open |
How Many Employees Work at Ramkamal Chemicals?
Ramkamal Chemicals has a workforce of 27 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ramkamal Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramkamal Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
